Love that this slipped completely past the market. If they hit the higher end of those revenue ranges this thing is wildly undervalued.
The amortization charges are making the bottom line look average, but free cash generation is great.
Hard to get an entry, that's the only problem.
- Forums
- ASX - By Stock
- Ann: CEO AGM Presentation
Love that this slipped completely past the market. If they hit...
Featured News
Add ESK (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.05M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 82498 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 103131 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.165 |
1 | 200000 | 0.150 |
1 | 65000 | 0.145 |
1 | 45000 | 0.140 |
1 | 68783 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 20000 | 1 |
0.200 | 19999 | 1 |
0.210 | 20000 | 1 |
0.220 | 21000 | 2 |
0.225 | 2964 | 1 |
Last trade - 16.12pm 22/11/2024 (20 minute delay) ? |
Featured News
ESK (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online